Recital 142, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

Fifth, the Parties submit that customers have ample opportunities to switch

suppliers and that switching can be done in a timely manner and without incurring significant costs, in particular because of the commodity nature of lactase. The Parties sustain that this is evidenced by the fact that: (i) switching between lactase suppliers and negotiations by customers happen quite frequently; and (ii) customers multi-source.